Breaking News Instant updates and real-time market news.

AAPL

Apple

$142.27

-2.02 (-1.40%)

, MSFT

Microsoft

$70.00

0.1 (0.14%)

12:32
06/18/17
06/18
12:32
06/18/17
12:32

Tech rally will resume, Barron's says

The rally in tech stocks such as Apple (AAPL), Microsoft (MSFT), Alphabet (GOOG), Facebook (FB) and Amazon (AMZN) "will resume," Barron's contends in a cover story. The sector will continue to generate strong earnings growth as technology proliferates throughout other industries, and many of the stocks look cheap, the publication says. Today's tech giants "look nothing" like the speculative names of the dot-com bust, Barron's adds. Reference Link

AAPL

Apple

$142.27

-2.02 (-1.40%)

MSFT

Microsoft

$70.00

0.1 (0.14%)

GOOG

Alphabet

$939.78

-2.53 (-0.27%)

GOOGL

Alphabet Class A

$958.62

-1.56 (-0.16%)

AMZN

Amazon.com

$987.71

23.54 (2.44%)

  • 20

    Jun

  • 28

    Jun

  • 19

    Jul

  • 20

    Jul

AAPL Apple
$142.27

-2.02 (-1.40%)

06/16/17
MSCO
06/16/17
NO CHANGE
Target $177
MSCO
Overweight
Recent Apple pullback largely due to overall tech weakness, says Morgan Stanley
Morgan Stanley analyst Katy Huberty believes the recent pullback in Apple shares, which are down 7% in the last week, is largely a result of overall weakness in the tech sector and not a change in investor sentiment towards the stock. She notes that Apple shares have risen an average of 18% in the 3 months prior to iPhone announcements over the last ten years, which she believes suggests the recent weakness creates an attractive opportunity to buy the stock. Huberyty keeps an Overweight rating and $177 price target on Apple.
06/15/17
UBSW
06/15/17
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit price target raised to $35 from $30 at UBS
UBS analyst Steven Milunovich raised his price target on Jabil Circuit (JBL) to $35 from $30 following solid Q3 results and its positive 2018 outlook. The analyst said the company still has a 24% revenue dependence on Apple (AAPL). Based on its guidance for 2018, it must have reasonable confidence in the iPhone 8 cycle, said Milunovich, who reiterated his Buy rating on Jabil shares.
06/15/17
COWN
06/15/17
NO CHANGE
Target $160
COWN
Outperform
Jabil Circuit results indicate no glaring issues for Apple, says Cowen
Cowen analyst Timothy Arcuri noted that Jabil Circuits' (JBL) results beat estimates and the company raised guidance. He said the read-through from the report indicate no glaring issues for the iPhone launch. His field work suggests Apple's (AAPL) June quarter is ok, but the September iPhone supply still appears roughly 3-4M below what is implied by the Street. Arcuri maintains his Outperform rating and $160 price target on Apple shares.
06/15/17
SBSH
06/15/17
NO CHANGE
Target $163
SBSH
Buy
Citi on Apple buying athenahealth? 'Never say never'
After CNBC reported that Apple (AAPL) is working on making the iPhone into a centralized management of patient health data, Citi analyst Garen Sarafian says athenahealth (ATHN) is a "well-suited candidate" to help. In a research note titled "Apple For athenahealth? Never Say Never," the analyst argues that athenahealth would accelerate Apple's efforts for interoperability. He believes Apple "would be one of few homes" that CEO Jonathan Bush would consider. Sarafian has a Buy rating on athenahealth with a $163 price target. The digital provider of medical records is down 42c to $142.34 in midday trading.
MSFT Microsoft
$70.00

0.1 (0.14%)

05/25/17
RBCM
05/25/17
NO CHANGE
RBCM
Microsoft named a favorite large cap software idea at RBC Capital
RBC Capital analyst MAtthew Hedberg named Microsoft one of his favorite large cap software ideas. The analyst expects the company to benefit from strong sales of its Azure and Office 365 products, as well as more efficient spending and increased commercial cloud margins.
06/16/17
KEYB
06/16/17
NO CHANGE
KEYB
Microsoft to benefit from cloud expansion, says KeyBanc
KeyBanc says that spending on the cloud could triple to $239B within five years, and the firm says that Microsoft (MSFT) "has the most to gain," as it thinks that the company is poised to surpass Amazon (AMZN) to become the sector leader. KeyBanc keeps a $78 price target and an Overweight rating on Microsoft.
06/15/17
NOMU
06/15/17
NO CHANGE
NOMU
Amazon.com price target raised to $1,100 from $975 at Nomura Instinet
Nomura Instinet analyst Anthony DiClemente says that Amazon's (AMZN) current valuation is "reasonable." The analyst says that, assuming the cloud business is worth $220B, based on a 2020 multiple similar to that given Microsoft (MSFT), while its Prime video business is worth $8B, or 12% of Netflix's (NFLX) current valuation, and its advertising business is worth $27B, or double his estimate of Snap's (SNAP) total valuation, the company's e-commerce business is only being valued at about $210B at current levels. Noting that Wal-Mart (WMT) is currently valued at $280B, the analyst says that Amazon's valuation "is not excessively strencthed." DiClemente raised his 2020 EV/EBITDA multiple for the cloud business to 14x from 13.5x, noting that SAP (SAP), Oracle (ORCL) and Microsoft (MSFT) all had higher multiples at similar points in their histories. The analyst raised his target multiple for Amazon's North America e-commerce business to 13x from 12x, which he says is in-line with Wal-Mart's mean multiple from 1992-2001. He raised his price target on Amazon to $1,100 from $975 and keeps a Buy rating on the stock.
06/15/17
BERN
06/15/17
NO CHANGE
BERN
Multiple software companies to benefit from AI, says Bernstein
Bernstein analyst Mark L. Moerdler believes that software companies will capture more than 50% of the revenue from AI. Multiple software companies will be able to benefit from the emergence of AI by creating "more efficient algorithms, " he believes. Microsoft (MSFT) will be well-positioned to use AI to drive adoption of its Azure cloud offering, while Adobe (ADBE) can use the technology to increase adoption of its cloud offerings and monetize AI through its IO product, the analyst believes. Splunk (SPLK) has added Machine Learning capabilities to its big data platform, and they are being used to deliver its security offerings, according to Moerdler. Over the longer term, the company should be able to incorporate machine learning into other products,the analyst stated. Oracle (ORCL) is benefiting from the use of AI in conjunction with its cloud offerings and from Machine Learning that it uses in conjunction with its data sources, the analyst stated. Finally, Salesforce's (CRM) Einstein Artificial Intelligence could give the company a competitive advantage over some competitors who do not offer similar functionality, he wrote. The analyst keeps Outperform ratings on all the stocks named except for Salesforce, which he continues to rate Underperform.
GOOG Alphabet
$939.78

-2.53 (-0.27%)

06/15/17
06/15/17
NO CHANGE

FANG fundamentals still strong but stocks may moderate, says Canaccord
Canaccord analyst Michael Graham noted the FANG stocks - Facebook (FB),Amazon (AMZN), Netflix (NFLX), and Google parent Alphabet (GOOG) - outpaced the S&P by a great deal and he feels even though fundamentals remain strong, the shares' momentum may begin to moderate. Graham believes most of the growth opportunities in tech remain with the FANG group but he believes valuations are quite reasonable. He downgraded Alphabet to Hold from Buy and believes that Amazon is the one to own long-term.
06/15/17
ADAM
06/15/17
DOWNGRADE
Target $1000
ADAM
Hold
Alphabet downgraded to Hold on valuation at Canaccord
As previously reported, Canaccord analyst Michael Graham downgraded Alphabet to Hold from Buy citing valuation. The analyst still believe growth opportunities exist but the valuation is inline and he believes investors should take a step back. Graham maintained his $1,000 price target on Alphabet shares.
06/15/17
06/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Hold from Buy at Canaccord with analyst Michael Graham citing valuation. Graham maintained his $1,000 price target on Alphabet shares. 2. Mattel (MAT) downgraded to Neutral from Buy at DA Davidson with analyst Linda Bolton saying near-term business fundamentals have deteriorated after the company cut its dividend by 61%. 3. Brinker (EAT) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe saying he expects higher spending and weak industry trends to offset any possible sales improvement. 4. Terex (TEX) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revinch citing valuation. 5. Splunk (SPLK) downgraded to Neutral from Outperform at Wedbush analyst Steve Koenig citing the emergence of "meaningful competition," the "complexity" of its transition to the cloud, and "somewhat messy fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/14/17
UBSW
06/14/17
NO CHANGE
Target $32
UBSW
Buy
Mindbody focus on high value subscribers the right strategy, says UBS
UBS analyst Ian Strgar said MindBody (MB) is now focused on high value subscribers, which he believes is the right strategy and should lead to a higher long-term average monthly revenue per subscriber, leading to a reacceleration of earnings and revenues. The analyst also sees the potential for an acquisition helping the strategy. He adds that its partnership with Google (GOOG) remains in its early innings and helps on the road to $1B in revenues. Strgar reiterated his Buy rating and raised his price target to $32 from $30 on MindBody shares.
GOOGL Alphabet Class A
$958.62

-1.56 (-0.16%)

06/15/17
ADAM
06/15/17
DOWNGRADE
ADAM
Hold
Alphabet downgraded to Hold from Buy at Canaccord
AMZN Amazon.com
$987.71

23.54 (2.44%)

06/16/17
BARD
06/16/17
NO CHANGE
BARD
Wal-Mart, Costco weakness on Amazon news a buying opportunity, says Baird
Baird analyst Peter Benedict said he we views Amazon's (AMZN) deal to buy Whole Foods (WFM) as reinforcing the value of local distribution and he believes Wal-Mart (WMT) and Costco (COST) are particularly well positioned to compete in the omni-channel grocery market. The analyst, who recommends using today's weakness in those two stocks as a buying opportunity, keeps an Outperform rating on both, while maintaining a Neutral rating on Target (TGT), noting that he thinks today's news "raises the bar" on its need to find an effective strategy to turn its grocery business.
06/16/17
JEFF
06/16/17
NO CHANGE
Target $88
JEFF
Buy
Wal-Mart should be rallying on Whole Foods takeover, says Jefferies
Jefferies analyst Daniel Binder views the "knee-jerk" selloff in Wal-Mart (WMT) shares following Amazon's (AMZN) acquisition of Whole Foods (WFM) as overdone. The deal suggests having a store base in food "is important after all," Binder tells investors in a research note. Investors should be buying Wal-Mart today, not "taking it to the woodshed," the analyst argues. The company has roughly 4,500 points of distribution in food while Amazon just bought 461, Binder writes in a research note titled "Stores Are Important After All!." He recommends buying Wal-Mart on the weakness today and keeps a Buy rating on the name with an $88 price target. The retailing giant is down 5%, or $3.67, to $75.24 in afternoon trading.
06/16/17
PIPR
06/16/17
NO CHANGE
Target $1200
PIPR
Overweight
Piper reiterates $1,200 target on Amazon following Whole Foods deal
Piper Jaffray analyst Michael Olson believes the importance of Amazon's (AMZN) acquisition of Whole Foods (WFM) centers on the accelerations in its grocery strategy. Amazon's proximity to the U.S. consumer with grocery delivery range locations will increase from 20%-30% to near ubiquity, which "significantly" accelerates its grocery go-to-market, Olson tells investors in a research note titled "The Future of Grocery is Bright, Disruptive and Amazon's." Further, he believes Whole Foods' localized sourcing can "significantly improve" Amazon's grocery SKU quality. He reiterates an Overweight rating on Amazon with a $1,200 price target.
06/16/17
06/16/17
DOWNGRADE

Neutral
Costco downgraded to Neutral from Conviction Buy at Goldman Sachs
As previously reported, Goldman downgraded Costco (COST) to Neutral from Conviction Buy and lowered its price target to $176 from $197. Analyst Matthew Fassler believes Costco's valuation will be capped due to Amazon's (AMZN) ongoing moves into consumables, online investments by Wal-Mart (WMT) and fading fundamental catalysts. He believes Amazon will offer superior pricing and delivery competency versus incumbents but does not anticipate meaningful erosion in warehouse business trends any time soon.

TODAY'S FREE FLY STORIES

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

16:57
09/22/17
09/22
16:57
09/22/17
16:57
Hot Stocks
Allergan receives refusal to file letter from FDA for Vraylar »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

HON

Honeywell

$141.75

0.89 (0.63%)

, CC

Chemours

$51.79

-0.16 (-0.31%)

16:51
09/22/17
09/22
16:51
09/22/17
16:51
Hot Stocks
Honeywell, Chemours seek rehearing of D.C Court decision regarding SNAP program »

Honeywell (HON) and…

HON

Honeywell

$141.75

0.89 (0.63%)

CC

Chemours

$51.79

-0.16 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$18.60

0.45 (2.48%)

16:46
09/22/17
09/22
16:46
09/22/17
16:46
Hot Stocks
Breaking Hot Stocks news story on Saint Joe Co. »

Fairholme raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
09/22/17
09/22
16:40
09/22/17
16:40
General news
Moody's downgrades UK's rating to Aa2, changes outlook to stable »

Moody's Investors…

A

Agilent

$65.78

-0.14 (-0.21%)

, MRK

Merck

$65.13

-0.47 (-0.72%)

16:36
09/22/17
09/22
16:36
09/22/17
16:36
Hot Stocks
Agilent receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 »

Agilent Technologies…

A

Agilent

$65.78

-0.14 (-0.21%)

MRK

Merck

$65.13

-0.47 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

TYHT

Shineco

$3.23

-0.45 (-12.23%)

16:35
09/22/17
09/22
16:35
09/22/17
16:35
Hot Stocks
Shineco enters into strategic cooperation to establish Apocynum Industrial Park »

Shineco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.16

0.03 (2.65%)

16:34
09/22/17
09/22
16:34
09/22/17
16:34
Hot Stocks
Appliance Recycling gets written notice of default »

On September 20,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

16:31
09/22/17
09/22
16:31
09/22/17
16:31
Hot Stocks
Rennova Health announces 1 for 15 reverse stock split »

Rennova Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.16

0.03 (2.65%)

16:31
09/22/17
09/22
16:31
09/22/17
16:31
Hot Stocks
Breaking Hot Stocks news story on Appliance Recycling »

Appliance Recycling gets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/22/17
09/22
16:30
09/22/17
16:30
Options
Preliminary option volume of 13.9M today »

Preliminary option volume…

EKSO

Ekso Bionics

$1.28

0.14 (12.28%)

16:23
09/22/17
09/22
16:23
09/22/17
16:23
Hot Stocks
Ekso Bionics awarded government contract »

The Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

, AET

Aetna

$153.57

0.18 (0.12%)

16:22
09/22/17
09/22
16:22
09/22/17
16:22
General news
On The Fly: Top stock stories for Friday »

The major averages…

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CI

Cigna

$182.74

0.61 (0.33%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

FSLR

First Solar

$51.41

2.65 (5.43%)

FINL

Finish Line

$9.73

0.51 (5.53%)

ASND

Ascendis Pharma

$34.24

6.5 (23.43%)

VSAR

Versartis

$2.68

-18.925 (-87.62%)

ICPT

Intercept

$61.59

-12.11 (-16.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Oct

DLR

Digital Realty

$114.51

-1.72 (-1.48%)

16:19
09/22/17
09/22
16:19
09/22/17
16:19
Syndicate
Breaking Syndicate news story on Digital Realty »

Digital Realty files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.